Advanced Biomed Inc. Common Stock
ADVBAdvanced Biomed Inc. is a medical technology company specializing in the integration of semiconductor and microfluidic technologies for oncology detection.
Table of contents
Earnings
Next report
Date not yet announcedCompetitors
By market cap
By revenue growth
Profile
Advanced Biomed Inc. is a medical technology company specializing in the integration of semiconductor and microfluidic technologies for oncology detection. The company develops advanced biochips and automated equipment designed for early cancer screening, diagnosis, and treatment monitoring through the enrichment and analysis of circulating tumor cells (CTCs). Its core value proposition lies in providing rapid, affordable, and label-free liquid biopsy solutions that maintain cell viability for downstream clinical applications.
The company positions itself as an innovative provider of antibody-free CTC enrichment technology, offering higher sensitivity and lower costs compared to traditional EpCAM-based methods.
Questions, answered.
- What is Advanced Biomed Inc. Common Stock's market cap?
- Advanced Biomed Inc. Common Stock (ADVB) has a market capitalization of $8.8M and trades on NASDAQ.
- Who are Advanced Biomed Inc. Common Stock's competitors?
- Advanced Biomed Inc. Common Stock's key competitors include Guardant Health, Onconetix, Inc. Common Stock, Agilent Technologies Inc., and others. These companies compete in similar markets and product categories.
- Who does Advanced Biomed Inc. Common Stock partner with?
- Advanced Biomed Inc. Common Stock's notable partners include Taiwan Semiconductor Research Institute, Riva, Unimold, and others.
- What subsidiaries does Advanced Biomed Inc. Common Stock have?
- Advanced Biomed Inc. Common Stock's subsidiaries include Advanced Biomed Taiwan, Advanced Biomed HK, Shanghai Sglcell.
- Where is Advanced Biomed Inc. Common Stock headquartered?
- Advanced Biomed Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2025.